We also demonstrated that GATA1 plays critical roles in sensitivities of megakaryocytic cells to cytarabine (ara-C) and daunorubicin (DNR), the two main drugs used for treating AML, through direct regulation of Bcl-xL. Here, BCL2L1 is linked to acute myeloid leukemia.